Antimicrobial dosages for adults with impaired kidney function: S

This table gives dosing recommendations for adults with impaired kidney function. For antimicrobial dosing in children with impaired kidney function, seek expert advice.

Table 1. Antimicrobial dosages for adults with impaired kidney function: S

[NB1]

saquinavir

sofosbuvir+velpatasvir

sofosbuvir+velpatasvir+voxilaprevir

sulfadiazine

saquinavir

Dosage adjustment based on GFR [NB2]

more than 50 mL/min

normal

10 to 50 mL/min

normal

less than 10 mL/min

normal

Dosages for dialysis [NB2]

intermittent haemodialysis

normal

peritoneal dialysis

normal

continuous renal replacement therapy

normal

sofosbuvir+velpatasvir

Dosage adjustment based on GFR [NB2]

more than 50 mL/min

normal

10 to 50 mL/min

normal

less than 10 mL/min

normal

Dosages for dialysis [NB2]

intermittent haemodialysis

normal

peritoneal dialysis

normal

continuous renal replacement therapy

normal

sofosbuvir+velpatasvir+voxilaprevir

Dosage adjustment based on GFR [NB2]

more than 30 mL/min

normal

10 to 30 mL/min

no data

less than 10 mL/min

no data

Dosages for dialysis

intermittent haemodialysis

no data

peritoneal dialysis

no data

continuous renal replacement therapy

no data

sulfadiazine

if GFR is less than 20 mL/min, monitor blood concentration if possible

Dosage adjustment based on GFR [NB2] [NB3]

more than 50 mL/min

normal

20 to 50 mL/min

avoid; if essential, normal

10 to 19 mL/min

avoid; if essential, 50% at normal dosing interval

less than 10 mL/min

avoid; if essential, 25% at normal dosing interval

Dosages for dialysis

intermittent haemodialysis

as for GFR less than 10 mL/min

peritoneal dialysis

continuous renal replacement therapy

as for GFR 10 to 20 mL/min

Note:

GFR = glomerular filtration rate

NB1: Dosing in patients with kidney impairment is complex. This table is intended as a guide only, see General considerations for antimicrobial dosage modification in kidney impairment. If relevant, see Dialysis and continuous renal replacement therapy for further guidance on using this table.

NB2: ‘Normal’ indicates that the standard dosage regimen for the specific indication in these guidelines should be used.

NB3: For multiple-daily doses, percentage dosage adjustments are calculated using the intermittent dose rather than the total daily dose (eg if standard dosing for drug X is 500 mg 6-hourly, then 50% at normal dosing interval = 250 mg 6-hourly, and 100% 12-hourly = 500 mg 12-hourly).